Johann Bartko

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid.

Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid.

Journal: Frontiers in medicine

Published: January 17, 2022

Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe.

Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe.

Journal: Journal of clinical medicine

Published: February 12, 2021

Fractal-Based Analysis of Bone Microstructure in Crohn's Disease: A Pilot Study.

Fractal-Based Analysis of Bone Microstructure in Crohn's Disease: A Pilot Study.

Journal: Journal of clinical medicine

Published: November 09, 2020

Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture.

Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture.

Journal: Journal of Crohn's & colitis

Published: March 15, 2020

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers.

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers.

Journal: Antimicrobial agents and chemotherapy

Published: February 17, 2019

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.

Journal: Blood

Published: June 08, 2018

Vascular cell adhesion molecule 1 in patients with severe osteoarthritis of the hip : A prospective cross-sectional study.

Vascular cell adhesion molecule 1 in patients with severe osteoarthritis of the hip : A prospective cross-sectional study.

Journal: Wiener klinische Wochenschrift

Published: April 24, 2018

A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.

A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.

Journal: Clinical pharmacology and therapeutics

Published: February 23, 2018

Reply: Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.

Reply: Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: December 18, 2017

Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers.

Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 14, 2017

Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM).

Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM).

Journal: Scandinavian journal of clinical and laboratory investigation

Published: October 31, 2017

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.

Journal: Transplantation

Published: September 20, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026